Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tick-Borne Encephalitis”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Not applicableActive Not RecruitingNCT05138055
What this trial is testing

The NOrwegian Tick-borne Encephalitis Study

Who this might be right for
Tick-Borne Encephalitis, European
Sykehuset Telemark 153
Post-approval studies (Phase 4)Study completedNCT03294135
What this trial is testing

The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

Who this might be right for
Virus Diseases
GlaxoSmithKline 194
Early research (Phase 1)Study completedNCT00118924
What this trial is testing

Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults

Who this might be right for
Tick-Borne Encephalitis
National Institute of Allergy and Infectious Diseases (NIAID) 28
Post-approval studies (Phase 4)Study completedNCT00311441
What this trial is testing

Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

Who this might be right for
Encephalitis, Tick-Borne
Novartis 300
Post-approval studies (Phase 4)UnknownNCT04573205
What this trial is testing

Primary TBE Vaccination for the Elderly

Who this might be right for
Tick-borne EncephalitisVaccine
Region Örebro County 90
Large-scale testing (Phase 3)Study completedNCT01361776
What this trial is testing

Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Who this might be right for
Tick-borne Encephalitis
Sormland County Council, Sweden 200
Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Testing effectiveness (Phase 2)UnknownNCT00890422
What this trial is testing

Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine

Who this might be right for
Tick Borne Encephalitis
Elisabethinen Hospital 99
Large-scale testing (Phase 3)Study completedNCT00460486
What this trial is testing

Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 330
Not applicableStudy completedNCT06593249
What this trial is testing

Management of Tick-borne Encephalitis

Who this might be right for
Infectious Encephalitis
University Medical Centre Ljubljana 318
Testing effectiveness (Phase 2)Study completedNCT01991067
What this trial is testing

Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients

Who this might be right for
Tick Borne Encephalitis
Medical University of Vienna 34
Not applicableLooking for participantsNCT07191223
What this trial is testing

Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France

Who this might be right for
Tick-borne Encephalitis, France
University Hospital, Strasbourg, France 100
Testing effectiveness (Phase 2)Study completedNCT00161889
What this trial is testing

FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer 615
Large-scale testing (Phase 3)Study completedNCT02318069
What this trial is testing

New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Who this might be right for
Tick-borne Encephalitis
Sormland County Council, Sweden 250
Post-approval studies (Phase 4)Study completedNCT00311493
What this trial is testing

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Who this might be right for
Encephalitis, Tick-Borne
Novartis 179
Post-approval studies (Phase 4)Study completedNCT00894686
What this trial is testing

Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 179
Large-scale testing (Phase 3)Study completedNCT00840801
What this trial is testing

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 302
Not applicableUnknownNCT02463942
What this trial is testing

Tick-borne Encephalitis and Positive Borrelial Antibodies

Who this might be right for
Tick-borne Encephalitis
University Medical Centre Ljubljana 100
Not applicableUnknownNCT00941590
What this trial is testing

Postencephalitic Symptoms After Tick Borne Encephalitis

Who this might be right for
Central European Encephalitis
University Medical Centre Ljubljana 200
Large-scale testing (Phase 3)Study completedNCT00161863
What this trial is testing

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Who this might be right for
Tick-borne Encephalitis
Pfizer
Load More Results